KENDALL GAMACHE: Open Payments
NPI 1720658362 · SANTEE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 18 payments from 11 companies in 2025. Trend: 2023 $214 · 2024 $640 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $86 |
| Novo Nordisk Inc | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Corcept Therapeutics | 2 | $44 |
| Alkermes, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $23 |
| Philips North America LLC | 1 | $22 |
| Verity Pharmaceuticals Inc. | 1 | $21 |
Products named: UBRELVY, AIRSUPRA, Korlym, QULIPTA, VIVITROL, GARDASIL 9, Dexcom G6 Transmitter, EVENITY.
Industry payments across CA — which companies pay providers there.
